REGENXBIO, Inc. (RGNX)
6.925
-0.24
(-3.28%)
USD |
NASDAQ |
Oct 16, 16:00
6.95
+0.02
(+0.36%)
After-Hours: 20:00
REGENXBIO Net Income (TTM) : -196.43M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -196.43M |
| March 31, 2026 | -290.01M |
| December 31, 2025 | -193.88M |
| September 30, 2025 | -177.92M |
| June 30, 2025 | -175.57M |
| March 31, 2025 | -157.69M |
| December 31, 2024 | -227.10M |
| September 30, 2024 | -238.80M |
| June 30, 2024 | -241.08M |
| March 31, 2024 | -260.15M |
| December 31, 2023 | -263.49M |
| September 30, 2023 | -260.54M |
| June 30, 2023 | -274.16M |
| March 31, 2023 | -270.27M |
| December 31, 2022 | -280.32M |
| September 30, 2022 | 73.64M |
| June 30, 2022 | 90.72M |
| March 31, 2022 | 101.26M |
| December 31, 2021 | 127.84M |
| September 30, 2021 | -212.42M |
| June 30, 2021 | -145.23M |
| March 31, 2021 | -121.35M |
| Date | Value |
|---|---|
| December 31, 2020 | -111.25M |
| September 30, 2020 | -91.47M |
| June 30, 2020 | -134.85M |
| March 31, 2020 | -102.54M |
| December 31, 2019 | -94.73M |
| September 30, 2019 | -63.96M |
| June 30, 2019 | -48.58M |
| March 31, 2019 | -36.53M |
| December 31, 2018 | 99.94M |
| September 30, 2018 | 79.63M |
| June 30, 2018 | 78.13M |
| March 31, 2018 | 53.06M |
| December 31, 2017 | -73.17M |
| September 30, 2017 | -76.78M |
| June 30, 2017 | -74.23M |
| March 31, 2017 | -74.19M |
| December 31, 2016 | -62.97M |
| September 30, 2016 | -48.54M |
| June 30, 2016 | -37.72M |
| March 31, 2016 | -29.57M |
| December 31, 2015 | -22.81M |
| September 30, 2015 | -16.84M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AbbVie, Inc. | 6.274B |
| United Therapeutics Corp. | 1.311B |
| Ardelyx, Inc. | -55.70M |
| Biomea Fusion, Inc. | -32.54M |
| RenovoRx, Inc. | -12.28M |